group balance training
OtherBalance training i group with focus on core stability exercises and dual attention activities.
NCT Number: NCT01582126
People with multiple sclerosis (MS) often have affected balance capacity and an increased risk for falls. A risk factor for falls are activities requiring dual attention. Another factor leading to reduced balance capacity is trunk stability, and decreased trunk stability has been seen in people with MS compared to healthy controls. Earlier studies using core stability exercises have shown positive effects on balance, compared to no training. In Sweden, physical therapy for people with MS has often included group training. However, evidence for this intervention is scarce. The aim of this study is therefore to investigate balance training in group. The balance training includes core stability exercises and dual attention activities. A multi-centre study is planned with a waiting-list design. Participants are randomised to either exercise group with early start or with late start. The group balance training includes training 60 minutes 2 times per week for 7 weeks.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Mälarsjukhuset, Eskilstuna, Sweden
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Balance training i group with focus on core stability exercises and dual attention activities.
Time frame: Change from Baseline in Bergs balance scale at 7 weeks
Functional balance scale in sitting, standing and walking.
Time frame: Change from Baseline in Four Square step test at 7 weeks
Dynamic balance
Time frame: Change from baseline in Times Chair stands test at 7 weeks
Functional leg strength, rising 10 times from a chair.
Time frame: Change from baseline in Timed Up and Go test at 7 weeks
Functional mobility.
Time frame: Change from baseline in Functional Gait Assessment at 7 weeks
Gait-related activities
Time frame: Change from baseline in Postural sway at 7 weeks
Using a sway meter postural sway in standing still is assessed.
Time frame: Change from baseline in Activities-specific Balance scale at 7 weeks
16 item questionnaire that includes items on balance self-efficacy
Time frame: Change from baseline in 12-item Multiple Sclerosis Walking scale at 7 weeks
self-reported limitations in walking.
Time frame: Change from Baseline in Bergs balance scale at 14 weeks
Functional balance in sitting, standing and walking
Time frame: Change from baseline in Four Square step test at 14 weeks
Dynamic balance
Time frame: Change from baseline in Times Chair stands test at 14 weeks
Functional lower extremity strength
Time frame: Change from baseline in Timed Up and Go test at 14 weeks
Functional mobility
Time frame: Change from baseline in Functional Gait Assessment at 14 weeks
Gait-related activities
Time frame: Change from baseline in postoral sway at 14 weeks
Using a sway meter postural sway in standing still is assessed.
Time frame: Change from baseline in Activities-specific Balance scale at 14 weeks
Balance self-efficacy
Time frame: Change from baseline in 12-item Multiple Sclerosis Walking scale at 14 weeks
self-reported limitations in walking
Örebro County Council
Other Gov
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03963375
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
St Louis, Missouri, United States
View Trial DetailsNCT02511028
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Bethesda, Maryland, United States
View Trial DetailsNCT07175792
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Diepenbeek, Belgium
View Trial DetailsNCT07726667
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Gaziantep, Gaz, Turkey (Türkiye)
View Trial Details